FOXA2 Antibody

1. might be a progesterone-induced gene, which may participate in the 'metastatic' process of eutopic endometrium to ectopic loci in patients with endometriosis PMID: 29233503
2. FOXA2 may act as a tumor suppressor and inhibit the epithelial-mesenchymal transition of endometrial cancer cells. PMID: 29442045
3. Our findings suggest that autophagy, through participation of FOXA2, maintains the characteristics of OCSCs. Autophagy and FOXA2 are therefore potential targets for ovarian cancer stem cell directed therapies. PMID: 29187221
4. MAPK and FoxA2 mediate CS-induced squamous metaplasia. MAPK inhibitors upregulate FoxA2, resulting in a reduction in the degree of squamous metaplasia. PMID: 29200841
5. In conclusion, our data suggest that overexpression of the Hedgehog components SHH, GLI2 and FOXA2 might be used as markers of an aggressive hemangioma. PMID: 28370639
6. Our results suggest that FoxA2 plays a key role in the expression of hepatic phenotype of AFP-producing adenocarcinomas. PMID: 28778497
7. FOXA2 is a specific and sensitive molecular marker for small cell neuroendocrine carcinoma of the prostate. PMID: 28621319
8. HNF3beta plays a vital role in regulation of CPS1 gene and could promote the metabolism of ammonia by regulating CPS1 expression. PMID: 28272778
9. The c.505T>C, p.S169P genetic variant occurs at the conserved forkhead DNA binding domain of the FOXA2 and causes a rare and unique clinical phenotype of hypopituitarism, CHI, dysmorphic features, liver, pancreas, heart and gastrointestinal abnormalities. PMID: 28973288
10. Results showed that FOXA2 expression was decreased during Il-13 induced goblet cell differentiation but DNA methylation of its promoter was not changed. In the absence of Il-13, no difference was found for FOXA2 expression but hypomethylation of CpG # 10 and 11 in the its promoter was detected. These findings suggest that aberrant DNA methylation of FOXA2 is one of the factors underlying mucus hypersecretion in COPD. PMID: 28450970
11. the findings of the current study provide compelling genetic evidence that FOXA2 is a pathogenic driver gene in the etiology of primary uterine cancers, including uterine carcinosarcomas and carcinomas. PMID: 28940304
12. Physical and functional interactions between LXRalpha and FOXA2 were established in vitro and ex vivo. PMID: 28576574
13. SIRT1 directly interacts with and deacetylates Foxa2 to inhibit its transcriptional activity on expression of genes involved in bile acids synthesis and transport. PMID: 27816442
14. Iotansulin decreased LPL mRNA levels in HepG2 cells and this was associated with phosphorylation of AKT and nuclear export of FOXA2. PMID: 28126606
15. findings provide the structural basis for FOXA2 protein binding to a consensus forkhead site and elucidate how members of the forkhead protein family bind different DNA sites. PMID: 28644006
16. Low FOXA2 expression is associated with metastasis of gastric cancer. PMID: 28098868
17. FOXA2 identified as a novel tumor suppressor in pancreatic cancer. It is regulated directly by miR-199a. PMID: 27151939
18. This study used combined immunohistochemical staining for a marker of hepatic commitment and specification (FOXA2 [Forkhead box A2]), hepatocyte maturation (Albumin and HepPar1), and features of bile ducts (CK19 [cytokeratin 19]) to identify lineages of stem cells differentiating toward the hepatocytic or bile ductular compartments of end-stage cirrhotic human liver. PMID: 27879410
19. Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomas. PMID: 28188614
20. The pattern of FOXA2 mutations and expression in tumors suggests complex regulation and a haploinsufficient or dominant-negative tumor suppressor function. PMID: 27538367
21. Study demonstrated downregulation of expression of pancreatic master genes SOX9, FOXA2, and GATA4 (2-, 5-, and 4-fold, respectively) and in PANC1 pancreatic cancer cell line stimulated with TGFbeta1 PMID: 27599506
22. The definitive endoderm and foregut endoderm differentiation capabilities of Wnt pathway-modulated cells were determined based on the expression levels of the endodermal transcription factors SOX17 and FOXA2 and those of the transcription activator GATA4 and the alpha-fetoprotein (AFP) gene, respectively. PMID: 26861571
23. Our results suggest that FOXA2 promotes cell proliferation, maintains cancer stem cells, favors the development of Triple-Negative/Basal-like tumors, and is associated with increase relapses. PMID: 26298189
24. FOXA2 regulates a network of genes involved in critical functions of human intestinal epithelial cells. PMID: 25921584
25. we propose that haploinsufficiency for FOXA2 combined with a decreased expression of NODAL is the likely cause for syndromic BA in this proband. PMID: 25765999
26. DEANR1 facilitates FOXA2 activation by facilitating SMAD2/3 recruitment to the FOXA2 promoter PMID: 25843708
27. Expression of FOXA2 is reduced in gastric adenocarcinoma tissues and its low-expression is correlated with malignant clinical pathological features PMID: 25940296
28. results provide opportunities to understand the FOXA2-centered transcriptional regulation network and novel therapeutic targets to modulate this network in p53-deficient lung cancer PMID: 26093302
29. FOXA2 as a core transcriptional modulator for pulmonary xenobiotic metabolic pathways; regulates pulmonary expression of CYP2A13 and ABCB1 PMID: 25667220
30. Results show that miR-141 functions as a tumor suppressor in hepatocellular carcinoma cells through the inhibition of HNF-3beta translation. PMID: 25425543
31. Study confirmed that FOXA2 inhibited EMT in breast cancer cells by regulating the transcription of EMT-related genes such as E-cadherin and ZEB2. PMID: 25779673
32. identification of transcription factors specific to early mesoderm commitment; FOXA2 observed to be the most significantly differentially expressed at human embryonic stem cell-endothelial cell day 2; FOXA2 transcription start site is marked with histone modifications for gene activation and repression PMID: 23618383
33. Results suggest that FOXA2 induced the differentiation of gastric cancer and highlight FOXA2 as a novel therapeutic tartet and prognostic marker for human gastric cancer. PMID: 25129104
34. we proved that FOXA2 repressed the transcription of matrix metalloproteinase (MMP)-9 and exerted its antimetastasis effect partially through downregulation of MMP-9. PMID: 25142974
35. this study demonstrates that SIRT1 controls the acetylation level of FOXA2 in a nutrient-dependent manner and in times of nutrient shortage the interaction between SIRT1 and FOXA2 is reduced. PMID: 24875183
36. Collectively, these studies demonstrated that Mycoplasma pneumoniae induces airway mucus hypersecretion by modulating the STAT/EGFR-FOXA2 signaling pathways. PMID: 25287927
37. results suggest a novel and unexpected role for DNA methylation in the activation of FoxA2 gene expression during differentiation PMID: 25016019
38. FOXA2 is acting as a master regulator of key pathways that are enriched for loci implicated by GWAS for most trait categories, with the clear exception of inflammation, suggesting that this factor exerts its effect via noninflammatory processes. PMID: 24878043
39. Respiratory epithelial cells express FOXA2 during different stages of lung development. PMID: 24970044
40. Knockdown of FoxO1 and ectopic expression of FoxA2 significantly decreased hepatitis C virus replication. PMID: 24478438
41. our study indicates that beta-catenin regulates Foxa2 expression, and this interaction is possibly essential to control cell cycle progression during endometrial hyperplasia formation PMID: 22945641
42. Upregulation of Foxa2 expression can enhance cIAP1, which inhibits the hepatocyte apoptosis. PMID: 23275033
43. epigenetic silencing of Foxa2 is associated with an increased DNA methylation level and histone H4 (Lys-20) trimethylation, decreased histone H3 acetylation and histone H3 (Lys-4) trimethylation, involved in cellular replicative or premature senescence. PMID: 23391216
44. VEGF may first downregulate expression of Foxa2 by enhancing Nur77 activity PMID: 22877565
45. These findings suggest that Foxa2 negatively regulates the basal transcription and expression of the human FTO gene. PMID: 23236435
46. Human Foxa2 efficiently promoted the incorporation of mesenchymal stem cells into damaged liver tissues. PMID: 22432472
47. The main mechanism of downregulation of Foxa2 is epigenetic silencing through promoter hypermethylation PMID: 22341411
48. FOXA2 rs1209523 was not significantly associated with fasting plasma glucose in glucose-tolerant individuals from the general Danish population of middle-aged people PMID: 22325233
49. These results suggest that increased sensitivity of the polymorphic matrix metalloproteinase 7 promoter to FOXA2 provides one of the genetic bases for the upregulation of matrix metalloproteinase 7 in idiopathic pulmonary fibrosis. PMID: 22268124
50. pFOXA2 expression is positively correlated with IKKalpha and activated NOTCH1 expression in tumor tissues. PMID: 22196886

Show More

Hide All

HGNC: 5022

OMIM: 600288

KEGG: hsa:3170

STRING: 9606.ENSP00000315955

UniGene: Hs.155651